A significant discovery in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital malignant suppressor protein is frequently disabled in many forms of tumors, causing https://orangebookmarks.com/story22005167/vhh-fragments-reactivate-p53-new-promising-hope-for-cancer-therapy